Immediate Impact
52 standout
Citing Papers
Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications
2024 Standout
Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents
2024 Standout
Works of Ki Young Yang being referenced
Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ki Young Yang | 217 | 240 | 120 | 15 | 383 | |
| Giulia Veronesi | 99 | 246 | 162 | 22 | 360 | |
| M Riggi | 54 | 313 | 153 | 16 | 444 | |
| D.C. Fermont | 114 | 111 | 112 | 10 | 352 | |
| Sallie S. Frankel | 170 | 154 | 169 | 10 | 344 | |
| Masato Sasaki | 162 | 277 | 187 | 13 | 418 | |
| U. Tiefenbacher | 142 | 183 | 91 | 13 | 357 | |
| Li Zhang | 214 | 181 | 99 | 19 | 351 | |
| Väinämö Nikkanen | 72 | 203 | 183 | 13 | 378 | |
| M. Takahashi | 173 | 91 | 79 | 16 | 417 | |
| Cheuk Man Chu | 74 | 154 | 46 | 19 | 384 |
All Works
Login with ORCID to disown or claim papers
Loading papers...